Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:FRA AEC DOC010 V.04 01-Jun-2018: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
Migrate to Template:DocumentData for PageForms (GxPlexBot)
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot)
 
Line 16: Line 16:
|contributors=
|contributors=
}}
}}
<noinclude>
== References ==
{| class="wikitable"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:FRA AEC_DOC010 V.04 01-Jun-2018 -]] || HM || - || FR || [...] I – DEMANDE D’AUTORISATION D’ESSAI CLINIQUE DE MEDICAMENT AUPRES DE L’ANSM PrĂ©ambule [...] PrĂ©alablement Ă  la mise en place en France d’un essai clinique de mĂ©dicament, le demandeur doit ...
|}
</noinclude>

Latest revision as of 14:15, 16 July 2026


Document information
Reference FRA AEC_DOC010 V.04 01-Jun-2018
Validity area FRA
Scope(s) HM
Document name AEC_DOC010 V.04
Version / Revision 01-Jun-2018
Status Current
Document type Official recommendation
Language(s) FR
Description AVIS AUX PROMOTEURS D’ESSAIS CLINIQUES DE MEDICAMENTS, Y COMPRIS LES ESSAIS CLINIQUES PORTANT SUR LES MEDICAMENTS DE THERAPIE INNOVANTE (MTI)

TOME I - DEMANDE D’AUTORISATION D’ESSAI CLINIQUE A L’ANSM, DEBUT DE L’ESSAI, MODIFICATIONS DE L’ESSAI ET FIN DE L’ESSAI.

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
FRA AEC DOC010 V.04 01-Jun-2018 -HM-FR[...]

I – DEMANDE D’AUTORISATION D’ESSAI CLINIQUE DE MEDICAMENT AUPRES DE L’ANSM PrĂ©ambule [...]

PrĂ©alablement Ă  la mise en place en France d’un essai

Retrieved from "https://gxplex.org/index.php?title=Document:FRA_AEC_DOC010_V.04_01-Jun-2018&oldid=20354"